On August 14, 2023, Exor announced that it had acquired a 10% stake in Philips for USD 10 billion. Exor is a holding company that invests in a variety of industries, including healthcare. The investment is seen as a vote of confidence in Philips' strategy and its commitment to innovation in healthcare.
On August 2, 2023, Philips announced that CEO Roy Jakobs had been appointed co-chair of the US National Academy of Medicine's Steering Committee on an AI Code of Conduct. The committee is tasked with developing a set of ethical principles for the development and use of artificial intelligence in healthcare.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5210
Published Date: Sep 01, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing demand from hospitals is the major factor driving the market growth.
The market size of lung assessment device is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Philips Healthcare, Medtronic, Masimo Corporation, GE Healthcare, BD (Becton, Dickinson and Company), Smiths Medical, and others.
The hospiatals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.